Chinese herbal medicines for hypertriglyceridaemia

被引:7
|
作者
Liu, Zhao Lan [1 ,2 ]
Li, George Q. [2 ]
Bensoussan, Alan [3 ]
Kiat, Hosen [4 ]
Chan, Kelvin [2 ,3 ]
Liu, Jian Ping [1 ]
机构
[1] Beijing Univ Chinese Med, Ctr Evidence Based Chinese Med, Beijing 100029, Peoples R China
[2] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia
[3] Univ Western Sydney, Sch Sci & Hlth, CompleMED, Sydney, NSW, Australia
[4] Macquarie Univ, Cardiac Hlth Inst, Australian Sch Adv Med, Sydney, NSW 2109, Australia
来源
COCHRANE DATABASE OF SYSTEMATIC REVIEWS | 2013年 / 06期
关键词
RANDOMIZED-TRIALS; QUALITY;
D O I
10.1002/14651858.CD009560.pub2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Hypertriglyceridaemia is associated with many diseases including atherosclerosis, diabetes, hypertension and chylomicronaemia. Chinese herbal medicines have been used for a long time as lipid-lowering agents. Objectives To assess the effects and safety of Chinese herbal medicines for hypertriglyceridaemia. Search methods We searched a number of databases including The Cochrane Library, MEDLINE, EMBASE and several Chinese databases (all until May 2012). Selection criteria Randomised controlled trials in participants with hypertriglyceridaemia comparing Chinese herbal medicines with placebo, no treatment, and pharmacological or non-pharmacological interventions. Data collection and analysis Two review authors independently extracted data and assessed the risk of bias. Any disagreement was resolved by discussion and a decision was achieved based on consensus. We assessed trials for risk of bias against key criteria: random sequence generation, allocation concealment, blinding of participants, incomplete outcome data, selective outcome reporting and other sources of bias. Main results We included three randomised trials with 170 participants. Ninety participants were randomised to the Chinese herbal medicines groups and 80 to the comparator groups with numbers ranging from 50 to 60 participants per trial. The duration of treatment varied from four to six weeks. All the included trials were conducted in China and published in Chinese. Overall, the risk of bias of included trials was unclear. There were no outcome data in any of the trials on death from any cause, cardiovascular or cerebrovascular events, health-related quality of life, or costs. Three different herbal medicines, including Zhusuan Huoxue decoction, Huoxue Huayu Tongluo decoction, and Chushi Huayu decoction were evaluated. All three trials investigating Chinese herbal medicines treatment alone (two studies) or in combination withgemfibrozil (one study) reported results on serum triglyceride (TG) in favour of the herbal treatment. We did not perform a meta-analysis due to significant clinical heterogeneity between the studies. No relevant differences in adverse effects occurred and no serious adverse events were noted. Authors' conclusions The present systematic review suggests that Chinese herbal medicines may have positive effects on hypertriglyceridaemia. The trials did not report serious adverse effects following Chinese herbal medicines treatment. However, based on an unclear risk of bias in included studies and lack of patient-important long-term outcomes, no definite conclusion could be reached.
引用
收藏
页数:40
相关论文
共 50 条
  • [1] Chinese herbal medicines for hypercholesterolemia
    Liu, Zhao Lan
    Liu, Jian Ping
    Zhang, Anthony Lin
    Wu, Qiong
    Ruan, Yao
    Lewith, George
    Visconte, Denise
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (07):
  • [2] Chinese herbal medicines for benign thyroid nodules in adults
    Wu, Wenxun
    Yin, Detao
    Yang, Weimin
    Kan, Quancheng
    Liu, Zhangsuo
    Ren, Xiaoyan
    Zhai, Chenguang
    Zhang, Shengjun
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (03):
  • [3] Chinese herbal medicines for treating osteoporosis
    Liu, Yunxia
    Liu, Jian Ping
    Xia, Yun
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (03):
  • [4] Chinese herbal medicines for esophageal cancer
    Wei, Xin
    Chen, Zhiyu
    Yang, Xiaoyan
    Wu, Taixiang
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (04):
  • [5] Cochrane Systematic Reviews of Chinese Herbal Medicines: An Overview
    Hu, Jing
    Zhang, Junhua
    Zhao, Wei
    Zhang, Yongling
    Zhang, Li
    Shang, Hongcai
    PLOS ONE, 2011, 6 (12):
  • [6] Chinese herbal medicines will illuminate the post-epidemic era
    Hao, Dacheng
    Liu, Changxiao
    CHINESE HERBAL MEDICINES, 2022, 14 (02) : 169 - 170
  • [7] Application progress of ultrasound in the production and processing of traditional Chinese herbal medicines
    Yang, Ke
    Han, Tao-hong
    Liu, Yi-jun
    Zhang, Jia-ning
    Zhou, Ping
    Yu, Xiao-ping
    ULTRASONICS SONOCHEMISTRY, 2024, 111
  • [8] Herbal medicines for fatty liver diseases
    Liu, Zhao Lan
    Xie, Liang Zhen
    Zhu, Jiang
    Li, George Q.
    Grant, Suzanne J.
    Liu, Jian Ping
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (08):
  • [9] Processing methods and mechanisms for alkaloid-rich Chinese herbal medicines: A review
    Li, Ruo-lan
    Zhang, Qing
    Liu, Jia
    He, Li-ying
    Huang, Qin-wan
    Peng, Wei
    Wu, Chun-jie
    JOURNAL OF INTEGRATIVE MEDICINE-JIM, 2021, 19 (02): : 89 - 103
  • [10] Chinese herbal medicines for people with impaired glucose tolerance or impaired fasting blood glucose
    Grant, Suzanne J.
    Bensoussan, Alan
    Chang, Dennis
    Kiat, Hosen
    Klupp, Nerida L.
    Liu, Jian Ping
    Li, Xun
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (04):